Want to see LFLH full AI Analyst Report?
Leafly Holdings (LFLH) AI Stock Analysis
Leafly Holdings
(Other OTC:LFLH)
The stock scores at the lowest end of the range due to significant weaknesses across all evaluated areas. The primary concerns are an unfavorable valuation, reflected by a negative P/E ratio indicating unprofitability, and a strong bearish technical trend with the price trading far below all key moving averages. The inability to assess financial performance due to unavailable data adds significant uncertainty.
Leafly Holdings (LFLH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $114.90M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -21.8
- Beta (1Y)
- -3.68
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 110
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Pharmaceuticals
Leafly Holdings Business Overview & Revenue Model
Company Description
Leafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. It offers subscription-based marketplace listings, digital advertising solutions, and...
How the Company Makes Money
Leafly generates revenue through multiple streams, primarily from digital advertising, subscription services, and partnerships with cannabis retailers. The company's advertising revenue comes from brands paying to promote their products on the Leafly...
Leafly Holdings Earnings Call Summary
While Leafly achieved a positive adjusted EBITDA and made strategic expansions, significant revenue declines, retail account reductions, and ongoing payment delinquencies present notable challenges. The positive aspects are countered by financial and operational hurdles.
Q2-2024 Updates
Positive Updates
Negative Updates
Company Guidance
During the Leafly Q2 2024 earnings call, the company provided guidance for the third quarter, projecting revenue of around $8.4 million and an adjusted EBITDA loss of less than $1 million. For Q2, Leafly reported revenue of $8.7 million, a net loss of $1.3 million, and a positive adjusted EBITDA of $483,000, surpassing guidance. The company highlighted a 6.4% reduction in retail accounts, ending the quarter with 3,595 accounts, and noted that payment delinquencies accounted for nearly 40% of the monthly recurring revenue lost. Despite a 25% year-over-year decline in brand revenue to $1.4 million, there was an observed increase from Q1, attributed to seasonal spending around the 420 holiday. Leafly also reported improvements in gross margin, which stood at 89%, and a decrease in operating expenses, down 17.5% year-over-year. The company continues to focus on operational efficiency and stabilizing revenues while expressing optimism about ongoing projects and market opportunities in regions like Ohio and Washington, D.C.
Leafly Holdings Financial Statement Overview
Summary
Financial performance cannot be assessed as the Income Statement, Balance Sheet, and Cash Flow scores are unavailable, representing a significant information gap and risk.
Leafly Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LFLH, the sentiment is Neutral. The current price of 37.00 is equal to the 20-day moving average (MA) of 37.00, equal to the 50-day MA of 37.00, and equal to the 200-day MA of 37.00, indicating a neutral trend. The MACD of indicates Neutral momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for LFLH.
Leafly Holdings Risk Analysis
Leafly Holdings disclosed 90 risk factors in its most recent earnings report. Leafly Holdings reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksLeafly Holdings Peers Comparison
Overall Rating
NEUP48Neutral
LFMD44Neutral
RNTX43Neutral- LFLH37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| NEUP | 48Neutral | $16.50M | -0.42 | -77.03% | ― | ― | ― |
| LFMD | 44Neutral | $110.38M | -4.51 | -179.12% | ― | -16.73% | -143.95% |
| RNTX | 43Neutral | $57.80M | -0.37 | -234.45% | ― | ― | 36.23% |
| LFLH | 37Underperform | $232.18K | -21.82 | 33.75% | ― | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LFLH | Leafly Holdings, Inc. | 37.00 | 0.00 | 0.00% | |
| RNTX | Rein Therapeutics, Inc | 0.67 | -1.08 | -61.71% | |
| LFMD | Lifemd, Inc. | 2.29 | -3.45 | -60.10% | |
| BAOS | Baosheng Media Group Holdings Ltd | 0.15 | -2.86 | -95.02% | |
| NEUP | Neuphoria Therapeutics Inc. | 3.05 | -1.33 | -30.37% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 23, 2025